Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria
- PMID: 12872834
- DOI: 10.1023/a:1024063726046
Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria
Abstract
Recent European studies have shown that growth retardation is com-mon in people with phenylketonuria (PKU) during the first years of life while they receive a low-phenylalanine (Phe) diet. The aims of the present study were to assess the growth of our PKU patients and to search for nutritional and hormonal explanations for the growth delay. Twenty PKU patients aged 8 months to 7 years entered the study. The design was cross-sectional, a longitudinal study having already been performed in our centre. The following data were recorded: weight/height (W/H), height/age (H/A), and weight/age (W/A) Z-scores; fat-free mass (measured from bioelectrical impedometry (FFM1), and skinfold thickness (FFMA). Thyroid hormones, insulin-like growth factor I (IGF1), insulin-like growth factor binding protein (IGFBP3), selenium, zinc, and Phe blood levels were measured. Dietary intake was also recorded over 4 days. PKU patients were moderately but significantly shorter (H/A Z-score varied from -2.12 to 1.61; mean -0.49) and lighter (W/A Z-score varied from -2.58 to 1.49; mean -0.71) than the French reference population. Body composition was not different from that of controls matched for age and sex. IGF1, IGFBP3, and thyroid hormone levels were within normal range. All children received more than two-thirds of the recommended daily allowances for energy (91% +/- 18%) and for proteins (146% +/- 26%). The mean daily intake of our patients was sufficient in selenium, but markedly deficient in zinc (2.4 +/- 2.2 mg/day). No correlation was found between zinc daily intake or zinc plasma levels and growth retardation. Moreover, no relation was found between the plasma Phe concentrations, protein or caloric intake and the presence of growth retardation. Our results show that growth retardation in PKU patients is not related to hormonal or caloric deficiencies. Further studies are needed to investigate the effect of various nutrient supplementation regimens (especially zinc) on the growth of PKU patients.
Similar articles
-
Dietary intake and nutritional status of patients with phenylketonuria in Taiwan.Sci Rep. 2020 Sep 3;10(1):14537. doi: 10.1038/s41598-020-71361-8. Sci Rep. 2020. PMID: 32883979 Free PMC article.
-
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.Orphanet J Rare Dis. 2019 Feb 15;14(1):44. doi: 10.1186/s13023-019-1011-y. Orphanet J Rare Dis. 2019. PMID: 30770754 Free PMC article. Review.
-
The relationship between dietary intake, growth and body composition in Phenylketonuria.Mol Genet Metab. 2017 Sep;122(1-2):36-42. doi: 10.1016/j.ymgme.2017.07.007. Epub 2017 Jul 20. Mol Genet Metab. 2017. PMID: 28739202
-
Early dietary treated patients with phenylketonuria can achieve normal growth and body composition.Mol Genet Metab. 2013;110 Suppl:S40-3. doi: 10.1016/j.ymgme.2013.10.009. Epub 2013 Oct 22. Mol Genet Metab. 2013. PMID: 24183791
-
Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature.J Inherit Metab Dis. 2007 Oct;30(5):694-9. doi: 10.1007/s10545-007-0549-3. Epub 2007 Jul 11. J Inherit Metab Dis. 2007. PMID: 17628756 Review.
Cited by
-
Homocysteine and methylmalonic acid in Phenylketonuria patients.Genet Mol Biol. 2024 Apr 5;46(3 Suppl 1):e20230103. doi: 10.1590/1678-4685-GMB-2023-0103. eCollection 2024. Genet Mol Biol. 2024. PMID: 38591937 Free PMC article.
-
Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria.Nutrients. 2023 Dec 18;15(24):5133. doi: 10.3390/nu15245133. Nutrients. 2023. PMID: 38140392 Free PMC article. Review.
-
Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis.Nutrients. 2023 Aug 8;15(16):3506. doi: 10.3390/nu15163506. Nutrients. 2023. PMID: 37630696 Free PMC article. Review.
-
Sex-Gender-Based Differences in Metabolic Diseases.Handb Exp Pharmacol. 2023;282:241-257. doi: 10.1007/164_2023_683. Handb Exp Pharmacol. 2023. PMID: 37528324
-
Phenylalanine free infant formula in the dietary management of phenylketonuria.Orphanet J Rare Dis. 2023 Jan 25;18(1):16. doi: 10.1186/s13023-023-02621-9. Orphanet J Rare Dis. 2023. PMID: 36698214 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous